DMFS was available in 1 study, which reported a borderline significant decreased HR in patients with higher lymphocyte counts.
← all excerpts
Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.
1
—
—